✦ LIBER ✦

Aromatization inhibition alone or in combination with GnRH agonists for the treatment of premenopausal breast cancer patients

✍ Scribed by Dowsett, M.; Stein, R.C.; Coombes, R.C.

Book ID: 122888426
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 396 KB
Volume: 43
Category: Article
ISSN: 0960-0760
DOI: 10.1016/0960-0760(92)90201-S

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical profiles of premenopausal breas

Clinical profiles of premenopausal breast cancer patients during tamoxifen treatment after adjuvant chemotherapy with GnRH agonist for ovarian protection

✍ N.Y. Kim; D.-Y. Lee; M.J. Kim; D. Choi 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Adjuvant therapy for operable breast can

Adjuvant therapy for operable breast cancer with medroxyprogesterone acetate alone in postmenopausal patients or in combination with CMF in premenopausal patients

✍ Pannuti, F.; Martoni, A.; Cilenti, G.; Camaggi, C.M.; Fruet, F. 📂 Article 📅 1988 🏛 Elsevier Science ⚖ 646 KB

Adriamycin alone or combined with vincri

Adriamycin alone or combined with vincristine in the treatment of advanced breast cancer

✍ Steiner, Rudolf; Stewart, John F.; Cantwell, Brian M.J.; Minton, Michael J.; Kni 📂 Article 📅 1983 🏛 Elsevier Science ⚖ 511 KB

62-Month follow-up of ABCSG-12: Adjuvant

62-Month follow-up of ABCSG-12: Adjuvant endocrine therapy, alone or in combination with zoledronic acid, in premenopausal patients with endocrine-responsive early breast cancer

✍ M. Gnant*; B. Mlineritsch; H. Stoeger; G. Luschin-Ebengreuth; S. Poestlberger; G 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 60 KB

A cathepsin k inhibitor (alone or in com

A cathepsin k inhibitor (alone or in combination with zoledronic acid) inhibits the progression of breast cancer bone metastases

✍ C. Le Gall; J. Guglielmi; J. Gasser ⁎; J. Zimmermann ⁎; P. Clézardin 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Anastrozole alone or in combination with

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer : Results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses

✍ The ATAC (Arimidex; Tamoxifen Alone or in Combination) Trialists' Group 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 2 views

## Abstract ## BACKGROUND The first analysis of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial (median follow‐up, 33 months) demonstrated that in adjuvant endocrine therapy for postmenopausal patients with early‐stage breast cancer, anastrozole was superior to tamoxifen in terms of d